| Name | Enpp-1-IN-14 |
|---|
| Description | ENPP1-IN-2 is a potent Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) inhibitor with an IC50 value of 32.38 nM for recombinant human ENPP-1. ENPP1-IN-2 has anti-tumor activity[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 32.38 nM (recombinant human ENPP-1)[1] |
| In Vivo | ENPP1-IN-2 (compound 015) (50 mg/kg; IP; BID, for 31 days) significantly inhibits tumor growth[1]. Animal Model: Female C57BL/6 mice (4-6 weeks; implanted subcutaneously with 2×105 MC38 cells)[1] Dosage: 50 mg/kg Administration: IP; BID, for 31 days (given a single 10 Gy exposure of focal radiation to the tumor site) Result: Significantly inhibited tumor growth. |
| References |
| Molecular Formula | C15H22ClN5O4S |
|---|---|
| Molecular Weight | 403.88 |
| Storage condition | -20°C |